Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Accounts Payables: 2013-2025

Historic Accounts Payables for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $6.3 million.

  • Ocular Therapeutix's Accounts Payables rose 56.46% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 56.46%. This contributed to the annual value of $4.2 million for FY2024, which is 4.85% down from last year.
  • According to the latest figures from Q3 2025, Ocular Therapeutix's Accounts Payables is $6.3 million, which was up 6.30% from $5.9 million recorded in Q2 2025.
  • Ocular Therapeutix's 5-year Accounts Payables high stood at $6.5 million for Q1 2024, and its period low was $3.4 million during Q1 2022.
  • Its 3-year average for Accounts Payables is $4.8 million, with a median of $4.4 million in 2023.
  • Per our database at Business Quant, Ocular Therapeutix's Accounts Payables spiked by 69.51% in 2021 and then decreased by 28.31% in 2025.
  • Over the past 5 years, Ocular Therapeutix's Accounts Payables (Quarterly) stood at $4.6 million in 2021, then grew by 11.56% to $5.1 million in 2022, then decreased by 14.33% to $4.4 million in 2023, then dropped by 4.85% to $4.2 million in 2024, then surged by 56.46% to $6.3 million in 2025.
  • Its Accounts Payables was $6.3 million in Q3 2025, compared to $5.9 million in Q2 2025 and $4.6 million in Q1 2025.